Dynamic Changes of Alkaline Phosphatase Are Strongly Associated With PSA-decline and Predict Best Clinical Benefit Earlier Than PSA-changes Under Therapy With Abiraterone Acetate in Bone Metastatic Castration Resistant Prostate Cancer

BMC Cancer - United Kingdom
doi 10.1186/s12885-016-2260-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients With Castration Resistant Prostate Cancer

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Mp52-11 Association of Dose Reduction of Abiraterone Acetate Plus Prednisone or Enzalutamide and Psa Progression in Veterans With Metastatic Castration Resistant Prostate Cancer

Journal of Urology
Urology
2018English

Prostate-Specific Antigen Decline After 4 Weeks of Treatment With Abiraterone Acetate and Overall Survival in Patients With Metastatic Castration-Resistant Prostate Cancer

European Urology
Urology
2016English

Pain, PSA Flare, and Bone Scan Response in a Patient With Metastatic Castration-Resistant Prostate Cancer Treated With Radium-223, a Case Report

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

A Prognostic Model for Stratifying Clinical Outcomes in Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

Canadian Urological Association Journal
Urology
2017English

A Phase 2 Trial of Abiraterone Acetate Without Glucocorticoids for Men With Metastatic Castration-Resistant Prostate Cancer

Cancer
Cancer ResearchOncology
2018English

Alkaline Phosphatase in Metastatic Castration-Resistant Prostate Cancer: Reassessment of an Older Biomarker

Future Oncology
MedicineCancer ResearchOncology
2018English

Metastatic Prostate Cancer With Highest Reported PSA Level

Acta Medica Marisiensis
2016English

Remarkable Response to Abiraterone Acetate in Castration-Resistant Prostate Cancer Patient With Aggressive Liver Metastasis

IJU Case Reports
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy